Ubiquitin (Ub) activators are a class of small molecules that play a crucial role in regulating the ubiquitin-proteasome system (UPS), a highly intricate and tightly controlled cellular machinery responsible for protein degradation. These compounds are essential for maintaining cellular homeostasis and ensuring the timely removal of damaged or misfolded proteins, which is critical for various cellular processes. Ubiquitin activators primarily function by facilitating the attachment of ubiquitin molecules to target proteins, marking them for degradation by the proteasome. At the heart of the Ubiquitin activation process lies the ubiquitin-activating enzyme (E1), which is responsible for initiating the ubiquitination cascade. Ub activators function by enhancing the activity of E1 enzymes, thereby promoting the transfer of ubiquitin molecules to E2 enzymes and subsequently to target proteins. This activation step is a pivotal point in the ubiquitination process, as it determines the efficiency and specificity of substrate recognition.
Ub activators can be further classified based on their specific mechanisms of action. Some compounds directly interact with E1 enzymes, stimulating their enzymatic activity, while others may affect the conjugation of ubiquitin to E2 enzymes or enhance the transfer of ubiquitin from E2 enzymes to substrates. Consequently, these activators ensure a finely tuned balance of protein turnover, allowing cells to regulate protein levels in response to various physiological signals and stress conditions. In summary, Ub activators are a diverse class of molecules critical for the proper functioning of the ubiquitin-proteasome system, a fundamental cellular process. By enhancing the activity of E1 enzymes or other key components in the ubiquitination cascade, these compounds ensure the efficient and precise tagging of proteins for degradation, thereby contributing to the maintenance of cellular integrity and function.
Produkt | CAS # | Katalog # | Menge | Preis | Referenzen | Bewertung |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Differenzierungsmittel, das die Reifung von Zellen der akuten promyelozytären Leukämie (APL) fördert. Könnte die RUNX1-Expression als Teil des Differenzierungsprogramms beeinflussen. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA-Methyltransferase-Inhibitor, der zum Schweigen gebrachte Gene reaktivieren kann. Könnte die RUNX1-Expression durch epigenetische Modifikationen beeinflussen. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
Steroidhormon, das verschiedene zelluläre Prozesse beeinflusst. Könnte in bestimmten Zusammenhängen einen indirekten Einfluss auf die RUNX1-Expression haben. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Glucocorticoid, das verschiedene zelluläre Prozesse, einschließlich der Hämatopoese, beeinflusst. Könnte die Expression von RUNX1 in bestimmten hämatopoetischen Abstammungslinien beeinflussen. |